Marinomed Signs Drug Discovery Collaboration with Bioalvo

Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies in virology and immunology, announced today the signing of a deal with the Portuguese company BIOALVO under which the two companies will collaborate to find drug candidates screened from BIOALVO’s PharmaBUG marine extract library. Financial terms were not disclosed. Under the terms of the deal BIOALVO will grant Marinomed access to BIOALVO’s PharmaBUG natural marine extracts. Marinomed will then have exclusive rights to use its own screening platform to identify those with therapeutic potential for indications in the areas of immunology and infectious diseases.

To learn more, please download the pdf file below...

• PharmaVentures_ Press Release_BLV_Marinomed.pdf